Author's posts
Fewer independent hospitals can weather operating headwinds
More independent hospitals are joining systems as they endure despite lower admissions and higher operating costs.
Week Ahead: Senate committee to grill Big Pharma on drug prices
Executives from seven major drugmakers, including Bristol-Myers Squibb Co., Merck & Co. and Pfizer are set to testify before the Senate Finance Committee on drug prices.
Hospitals test ways to address social needs
The American Hospital Association’s Hospital Community Cooperative seeks to learn better approaches to managing population health from providers that have spent years addressing such issues.
Q&A: Alliance for Better Health CEO Jacob Reider on achieving interoperability
One of the top issues at HIMSS19 this month was the need to rethink and broaden services provided to patients. Jacob Reider, former federal deputy national coordinator of health IT, has thoughts on how to do that.
Minor league team takes peanuts off the menu
After a plea from a mother with an allergic son, the Hartford (Conn.) Yard Goats are taking the baseball field this year with some things missing from the concession stand: peanuts and Cracker Jack.
CEO Power Panel: M&A no longer health systems’ top growth strategy
Members of Modern Healthcare’s CEO Power Panel say the allure of mergers and acquisitions may be losing its stronghold over health system leaders. Finances may slide in 2019, but CEOs insist it’s for good reason.
As value-based efforts lag, push for price regulation gains momentum
Advocates argue that price controls are needed because competition is failing as providers, insurers and manufacturers become larger and larger.
Boost Obamacare or push for single-payer? Democrats face tough decisions on the road to 2020
The Affordable Care Act helped Democrats regain control of the House in 2018. But is the status quo enough to stave off progressives’ demand for movement to a single-payer program?
Optum loses bid to stop ex-executive from working at Amazon-Berkshire-JPMorgan joint venture
UnitedHealth Group-owned Optum lost its legal fight Friday to block a former executive from working at Amazon, Berkshire Hathaway and JPMorgan Chase’s new healthcare cost-saving venture.
Senate panel to probe high insulin prices
The Senate Finance Committee is demanding top insulin makers explain why prices for the lifesaving drug are so high.
